Which Injectable Categories Should Be Prioritised This Summer? A Clinical Selection Guide

Clinical education article · Updated July 2026 · 7 min read

Evidence level: established clinical literature (HA rehydration, bio-remodelling, amino-acid mesotherapy) + emerging in-vitro/preclinical mechanistic evidence (polynucleotide photoprotection).

Summer does not remove options from the injectable menu — it narrows the criteria for choosing between them. Heat, UV load, sweat, chlorine and salt exposure, and a patient base that will not accept visible downtime all shift the calculus toward categories that tolerate the season and, in one case, actively work with it. This article maps four injectable categories that hold up through peak season, the products that anchor each one, and the single variable — post-inflammatory hyperpigmentation risk in higher phototypes — that changes product selection rather than treatment eligibility.

Why Summer Changes the Selection Criteria

Body and facial skin under summer conditions carries a different tissue burden than the same skin in autumn or winter: higher cumulative UV exposure, increased transepidermal water loss from heat and air conditioning, and repeated contact with chlorinated or salt water. Patients also arrive with a lower tolerance for downtime and a stronger preference for visible, fast-normalising results — a scheduling constraint as much as a clinical one.

None of this rules out injectable treatment. It does mean that category selection should account for erythema resolution time, tolerance in sun-exposed skin, and — for any product with a pigmentation-adjacent mechanism — phototype. The four categories below are the ones that meet those conditions without compromising on indication.

For clinics that ran a spring regeneration reset, these four categories are the direct continuation of that logic into peak UV season — see Spring Skin Quality Protocols: PDRN, Biostimulators & Skin Boosters for the pre-summer groundwork.

Four Categories, Four Distinct Clinical Rationales

Each category below addresses a different biological deficit. They are not interchangeable, and a well-built summer protocol typically draws on more than one — sequenced according to the patient’s dominant presentation, not run as a single undifferentiated “summer package”.

1. Rehydration — Non- and Low-Cross-Linked HA

The most direct summer indication: intradermal water replacement for skin under sun, wind, air-conditioning and salt or chlorine load. This is a superficial-dermis intervention aimed at surface hydration and radiance, not structural correction.

Products commonly selected by clinics for this indication:

• Stylage Hydro Bi-Soft — non-cross-linked HA with mannitol, an antioxidant buffer against UV- and pollution-driven HA degradation. Face, neck, décolleté.
• Refine+ Ultra Soft — weakly cross-linked HA at 20 mg/ml, for a longer-held effect where the deficit runs deeper than pure mesotherapy addresses. Face, neck, hands.

Clinics building a rehydration protocol typically start with a series, then move to maintenance. Browse the full skin booster range →

2. Regeneration — Polynucleotides

The category in this list with the strongest mechanistic rationale for summer use — see the dedicated section below.

Products commonly selected by clinics for this indication:

• Nucleofill Strong — 2.5% polynucleotide gel, HA-free, for bio-stimulation, density and firmness. 2–4 sessions, 3–4 weeks apart.

Clinics building a regeneration protocol pair this with rehydration where surface dehydration is also present. Browse the full polynucleotide and biostimulator range →

3. Bio-Remodelling — High-Concentration HA

Distinct from rehydration: this category targets structural remodelling where the presenting deficit is skin quality and laxity, not simply surface water content.

Products commonly selected by clinics for this indication:

• Profhilo H+L — hybrid HA (64 mg/2 ml), no cross-linker, spreads evenly and remodels rather than fills. Two sessions, four weeks apart.

Clinics building a bio-remodelling protocol reassess before layering rehydration or maintenance on top. Browse the full skin booster range →

4. Maintenance — Amino-Acid Mesotherapy

Texture and elasticity upkeep without the downtime patients will not accept mid-season. This is the lightest-touch category of the four and the easiest to schedule around a summer calendar.

Products commonly selected by clinics for this indication:

• Jalupro — HA with glycine, L-proline, L-leucine and L-lysine; fibroblast substrate rather than volumetric fill. Monthly series, gradual effect.

Clinics use this category to hold results between other layers or as a standalone holiday-friendly visit. Browse the full mesotherapy range →

Comparative Overview

Why Traditional HA Fillers Aren’t the Starting Point for a Summer Skin-Quality Protocol

Classic volumising HA fillers are not excluded from summer treatment planning — patients with genuine volume loss still need them, in any season. But they solve a different problem than the four categories above. Fillers correct soft-tissue volume deficit at the subcutaneous or deep-dermal plane; none of the four summer categories in this article do that, and volumising fillers do not address the surface hydration, dermal quality or fibroblast-substrate deficits that dominate summer presentations.

In practice, this means a patient asking about “something for tired, dehydrated summer skin” is describing a rehydration or maintenance case, not a filler case. Reaching for a volumising filler on that presentation treats the wrong layer and does not resolve the complaint. Filler placement remains appropriate once genuine volume loss is the primary finding — typically assessed separately from, and after, the skin-quality categories discussed here.

Why Polynucleotides Deserve Special Attention This Summer

Of the four categories, polynucleotides currently have the strongest mechanistic rationale for summer use, beyond simple tolerance. A 2025 study published in PLOS ONE examined polydeoxyribonucleotide (PDRN) in human keratinocytes exposed to UVB radiation or hydrogen peroxide (H ₂ O ₂ ) — two established models of extrinsic photoageing and oxidative stress. PDRN treatment mitigated the decline in cell viability, reduced markers of cellular senescence, and preserved expression of SIRT1, a deacetylase whose levels decline with both chronological ageing and stress-induced cellular senescence. Mechanistically, the effect was linked to reduced nuclear autophagy and preservation of SIRT1 and p62 in the cytoplasm under UVB and H ₂ O ₂ stimulation. ^[1]

This sits alongside an earlier and more established line of evidence on PDRN and melanogenesis. Work published in the International Journal of Molecular Sciences in 2016 demonstrated that PDRN reduces intracellular tyrosinase activity and downregulates MITF and TRP-1 — the transcriptional machinery driving melanin synthesis — in both melanocyte and melanocyte-keratinocyte coculture models, with a small clinical evaluation showing improvement in facial hyperpigmentation after three sessions of intradermal PDRN. ^[2]

Neither finding constitutes a treatment guideline, and both are preclinical or early-phase in nature. But directionally, they point the same way as the phototype caution discussed below: polynucleotides are not merely tolerated under summer UV load — the available mechanistic data suggest they may actively work with it, rather than against it, particularly in the context of the melanogenesis-suppressing profile relevant to higher phototypes.

For the full molecular breakdown of PN vs PDRN — molecular weight, receptor kinetics and product selection — see Polynucleotides vs PDRN: Mechanisms, Protocols and Product Selection .

Phototype and PIH: A Selection Parameter, Not a Reason to Pause

The one variable that genuinely changes across the four categories in summer is post-inflammatory hyperpigmentation (PIH) risk in higher Fitzpatrick phototypes. This is not a reason to defer treatment through the season — it is a parameter that should inform product and technique choice within each category, in the same way it would at any other time of year with heightened UV exposure.

In practice, this means: favouring lower-trauma injection techniques and adequate photoprotection counselling across all four categories in phototypes IV–VI; treating any active PIH or recent inflammatory event before layering additional injectable treatment on top of it; and, where the presentation includes both skin-quality deficit and pigmentation concern, giving polynucleotides — with their documented antioxidant and melanogenesis-suppressing profile — priority sequencing over categories with no such mechanism.

Building a Summer Protocol

A fast way to route a summer consultation to the right starting category:

Most patients presenting through summer fall into one of three profiles. The table below maps profile to category and typical sequencing.

Key Takeaways

• Four injectable categories run safely through summer: rehydration, regeneration (polynucleotides), bio-remodelling and amino-acid mesotherapy — each addressing a distinct biological deficit.
• Polynucleotides currently offer one of the strongest mechanistic rationales for summer use of the four categories: 2025 PLOS ONE data show PDRN protecting keratinocytes against UVB- and oxidative-stress-induced senescence via SIRT1 preservation. ^[1]
• Earlier evidence documents PDRN suppression of tyrosinase activity and melanogenesis-related transcription factors — mechanistically aligned with, not opposed to, the phototype caution. ^[2]
• Phototype and PIH history are a product-and-technique selection parameter across all four categories in summer — not a reason to defer treatment.
• A layered summer protocol — rehydration, regeneration, bio-remodelling and maintenance sequenced to the patient’s dominant deficit — outperforms a single undifferentiated “summer package”.

References

Frequently Asked Questions

Is it safe to run polynucleotide or HA treatments through peak summer sun exposure?

Yes, across all four categories. The relevant caution is phototype- and PIH-history-specific, not a categorical seasonal contraindication. Standard photoprotection counselling and, in higher phototypes, closer attention to injection technique are the applicable safeguards.

Which category should be prioritised for a patient with existing post-inflammatory hyperpigmentation?

Active PIH should be addressed before additional injectable treatment is layered on top of it. Once tissue is stable, polynucleotides carry the most directly relevant mechanistic profile given their documented suppression of tyrosinase activity and melanogenesis-related transcription factors.

Can rehydration and regeneration categories be combined in the same summer protocol?

Yes. They address different biological deficits — surface hydration versus fibroblast-level bio-stimulation — and are frequently sequenced together, typically with rehydration addressed first where dehydration is the dominant presenting concern.

Why does bio-remodelling with high-concentration HA differ from rehydration?

Rehydration products (non- or low-cross-linked HA) primarily replace water content at the superficial dermis. Bio-remodelling products such as Profhilo H+L are formulated to spread through tissue and stimulate structural remodelling — indicated where the presentation includes laxity and textural change, not just surface dehydration.

How does amino-acid mesotherapy fit into a summer treatment calendar?

As the lowest-downtime option of the four, amino-acid mesotherapy (e.g. Jalupro) is well suited to monthly maintenance visits patients can schedule around holidays and social commitments without visible recovery time.